A Prospective, Post Marketing Observational Study to Evaluate the Safety of Pletaal SR Capsule
Latest Information Update: 18 Feb 2019
At a glance
- Drugs Cilostazol (Primary)
- Indications Cerebral infarction; Embolism and thrombosis
- Focus Adverse reactions
- Acronyms PLTSRPMOS
- Sponsors Korea Otsuka Pharmaceutical
- 14 Sep 2018 Status changed from not yet recruiting to completed.
- 11 Feb 2013 New trial record